# An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

> **NCT01018238** · PHASE1 · WITHDRAWN · sponsor: **Novo Nordisk A/S**

## Conditions studied

- Inflammation
- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** NNC 0151-0000-0000
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01018238
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-11
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** See detailed description
- **Last updated:** 2014-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018238, "An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01018238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*